Lupus Monitor Profile

CPT: 83516; 86160(x4); 86225
Updated on 12/5/2024
Print Share

Test Includes

Complement C3 [006452]; Complement C3a [004220]; Complement C4 [001834]; Complement C4a [004330]; dsDNA Antibody by IFA, Crithidia luciliae, with Reflex to Titer [096346]; Anti-C1Q Ab, IgG [505710]


Special Instructions

State the patient's sex and age on the test request form.

For Complement C3a [004220] and Complement C4a [004330]: Futhan preservative must be added to samples immediately after collection. Collection kits containing this preservative are available as Labcorp Part No. 78946.

Testing for Anti-C1q Ab, IgG currently is not available in New York state.

State the patient's sex and age on the test request form.

For Complement C3a [004220] and Complement C4a [004330]: Futhan preservative must be added to samples immediately after collection. Collection kits containing this preservative are available as Labcorp Part No. 78946.

Testing for Anti-C1q Ab, IgG is not approved for New York state clients.

State the patient's sex and age on the test request form.

For Complement C3a [004220] and Complement C4a [004330]: Futhan preservative must be added to samples immediately after collection. Collection kits containing this preservative are available as Labcorp Part No. 78946.

Testing for Anti-C1q Ab, IgG currently is not available in New York state.


Expected Turnaround Time

3 - 5 days


Related Information


Related Documents

For more information, please view the literature below.

Lupus Comprehensive Testing Brochure


Specimen Requirements


Specimen

Serum, EDTA plasma with Futhan (frozen)


Volume

2 mL serum, 2 mL EDTA plasma with Futhan


Container

Gel-barrier tube, lavender-top (EDTA) tube, screw cap tube with Futhan


Test Details


Use

This profile is used to aid in monitoring treatment for Lupus patients.


Limitations

For Complement C3a [004220] and Component C4a [004330]: Results of this test are labeled for research purposes only by the assay's manufacturer. The performance characteristics of this assay have not been established by the manufacturer. The result should not be used for treatment or for diagnostic purposes without confirmation of the diagnosis by another medically established diagnostic product or procedure. The performance characteristics were determined by Labcorp.


Methodology

See individual components.


LOINC® Map

For Providers

Please login to order a test

Order a Test

© 2021 Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.

CPT Statement/Profile Statement

The LOINC® codes are copyright © 1994-2021, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at https://loinc.org/license/. Additional information regarding LOINC® codes can be found at LOINC.org, including the LOINC Manual, which can be downloaded at LOINC.org/downloads/files/LOINCManual.pdf